Modulation of vasodilator-stimulated phosphoprotein in vivo in human epithelial cells by segmental allergen challenge and beta2-agonist therapy.
Hastie
Annette T
AT
Thomas Jefferson University, Philadelphia, PA 19107, USA. annette.hastie@mail.tju.edu
Batra
Vikas
V
Khurana
Sandhya
S
Carpenter
Kathy A
KA
Cirelli
Rosemary
R
Zangrilli
James G
JG
Peters
Stephen P
SP
D058666:Adrenergic beta-2 Receptor Agonists; D016525:Antigenic Modulation / Q000187:drug effects*; D001249:Asthma / Q000188:drug therapy*; D001985:Bronchial Provocation Tests; D015815:Cell Adhesion Molecules / Q000187:drug effects*; D004847:Epithelial Cells / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008840:Microfilament Proteins; D010750:Phosphoproteins / Q000187:drug effects*; D018343:Receptors, Adrenergic, beta-2 / Q000627:therapeutic use*; D000098662:Vasodilator-Stimulated Phosphoprotein
D058666:Adrenergic beta-2 Receptor Agonists; D015815:Cell Adhesion Molecules; D008840:Microfilament Proteins; D010750:Phosphoproteins; D018343:Receptors, Adrenergic, beta-2; D000098662:Vasodilator-Stimulated Phosphoprotein